Epileptic and neurodevelopmental encephalopathy associated to SYNGAP1 mutation: Description of a case and treatment response to cannabidiol
Main Authors: | Y. López-Moreno, P. Cabezudo-García, N.L. Ciano-Petersen, G. García-Martín, P.J. Serrano-Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2024-01-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580823000640 |
Similar Items
-
Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy
by: Mathieu Kuchenbuch, et al.
Published: (2020-09-01) -
Behavioural and neurodevelopmental characteristics of SYNGAP1
by: Nadja Bednarczuk, et al.
Published: (2024-08-01) -
Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review
by: Xingying Zeng, et al.
Published: (2023-02-01) -
Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy
by: Juliana Ribeiro-Constante, et al.
Published: (2024-03-01) -
KCNB1 Mutations in Epileptic Encephalopathy
by: J Gordon Millichap, et al.
Published: (2014-12-01)